Author of the publication

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . Human molecular genetics, 20 (23): 4732–4747 (2011)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer, , , , , , , , , and 427 other author(s). Nature genetics, 45 (4): 371-84, 384e1-2 (2013)Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers, , , , , , , , , and 99 other author(s). Human molecular genetics, 20 (23): 4732–4747 (2011)Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 169 other author(s). Human molecular genetics, 20 (16): 3304–3321 (2011)Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers, , , , , , , , , and 63 other author(s). Breast cancer research : BCR, 12 (6): R102 (2010)Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 176 other author(s). Human mutation, 33 (4): 690–702 (2012)Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction, , , , , , , , , and 168 other author(s). Cancer research, 70 (23): 9742–9754 (2010)The effectiveness of a graphical presentation in addition to a frequency format in the context of familial breast cancer risk communication: a multicenter controlled trial., , , , , , , and . BMC Medical Informatics Decis. Mak., (2013)BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk, , , , , , , , , and 23 other author(s). Journal of medical genetics, 49 (8): 525–532 (2012)